Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea
· Delayed Price · Currency is KRW 1,019,000
-10,000 (-0.97%)
At close: Jun 13, 2025, 3:30 PM KST
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 72.53 trillion as of June 13, 2025. Its market cap has increased by 30.47% in one year.
Market Cap
72.53T
Enterprise Value
72.66T
Revenue
4.90T
Ranking
n/a
PE Ratio
56.68
Stock Price
1,019,000.00
Market Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 72.53T, an increase of 661.21%. That is a compound annual growth rate of 26.64%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 36.24T |
| ALTEOGEN | 21.94T |
| Yuhan | 8,029.03B |
| SK Biopharmaceuticals | 7,322.29B |
| HLB Co., Ltd. | 7,004.29B |
| PharmaResearch | 5,433.79B |
| Peptron | 4,487.07B |
| LigaChem Biosciences | 4,256.00B |